Christiana Bardon, M.D., M.B.A.
Dr. Christiana (Chris) Bardon oversees the public equity component of MPM’s oncology-only crossover investment strategy that donates a portion of its profits and royalties to cancer care and research.
Chris is also the founder and managing member of Burrage Capital, a long/short equity manager in biotechnology and healthcare. Previously, she was a health care analyst at Fidelity Investments covering biotechnology, life science tools and diagnostics. She started her career as an analyst at MPM and currently serves on the Harvard Medical School Board of Fellows.
Chris earned her M.D. magna cum laude from Harvard Medical School and her M.B.A. from Harvard Business School. While at Harvard Medical School, she was the recipient of a Howard Hughes fellowship. She also completed a residency in Internal Medicine at the Brigham and Women’s Hospital at Harvard Medical School. She also received her M.S./B.S. from the Massachusetts Institute of Technology.